MSONTHI LEVINE: Open Payments
NPI 1962430413 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 35 payments from 13 companies in 2025. Trend: 2023 $1,186 · 2024 $1,558 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $238 |
| PFIZER INC. | 3 | $77 |
| Amgen Inc. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Inspire Medical Systems, Inc. | 2 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Novo Nordisk Inc | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: CREON, UBRELVY, INSPIRE, OTEZLA, ELIQUIS, GEMTESA, REXULTI, BREZTRI.
Industry payments across TX — which companies pay providers there.
